Home/Filings/4/0001209191-13-052739
4//SEC Filing

ROCHESTER MEDICAL CORPORATION 4

Accession 0001209191-13-052739

CIK 0000868368operating

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 12:35 PM ET

Size

18.8 KB

Accession

0001209191-13-052739

Insider Transaction Report

Form 4
Period: 2013-11-14
Carper James M
VP Marketing
Transactions
  • Award

    Common Stock

    2013-11-14+13,88914,389 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$9.11/sh5,000$45,5500 total
    Exercise: $10.89From: 2009-02-12Exp: 2018-02-12Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$7.73/sh20,000$154,6000 total
    Exercise: $12.27From: 2011-01-28Exp: 2020-01-28Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$9.28/sh20,000$185,6000 total
    Exercise: $10.72From: 2012-01-27Exp: 2021-01-27Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$1.98/sh5,000$9,9000 total
    Exercise: $18.02From: 2008-03-13Exp: 2017-03-13Common Stock (5,000 underlying)
  • Disposition to Issuer

    Common Stock

    2013-11-14$20.00/sh14,389$287,7800 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2013-11-14$8.73/sh20,000$174,6000 total
    Exercise: $11.27From: 2010-02-03Exp: 2019-02-03Common Stock (20,000 underlying)
Footnotes (3)
  • [F1]On November 14, 2013 the restricted stock units vested, in accordance with the related award agreements and the Agreement and Plan of Merger dated September 3, 2013 (the "Merger Agreement") among Rochester Medical Corporation (the "Company"), C.R. Bard, Inc., a New Jersey Corporation ("Bard"), and a wholly owned subsidiary of Bard, upon the effectiveness of the merger contemplated by the Merger Agreement (the "Merger") and were simultaneously cancelled in exchange for the right to receive a cash payment of $20.00 for each unit, without interest and less any applicable withholding taxes.
  • [F2]On November 14, 2013 at the effective time of the Merger, these shares of Company common stock were cancelled and converted into the right to receive a cash payment of $20.00 per share, without interest and less any applicable withholding taxes.
  • [F3]These options originally provided for vesting in 25% annual cumulative installments beginning the date set forth. Pursuant to the Merger Agreement, upon the effectiveness of the Merger the vesting of these options was accelerated and they were cancelled in exchange for the right to receive a cash payment per option equal to the excess of $20.00 over the per share exercise price of the option.

Issuer

ROCHESTER MEDICAL CORPORATION

CIK 0000868368

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000868368

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 12:35 PM ET
Size
18.8 KB